Obesity pill for diabetes treatment

Fri, 27 Oct 2006
A pill designed to treat obesity could also help to control blood sugar levels amongst patients who are suffering from type 2 diabetes, according to researchers. Type 2 diabetes drugs are sometimes effective in aiding weight loss, yet this is one of the first to operate the other way.

Apparently, the Sanofi-Aventis drug Acomplia, also known in the trade as Rimonabant, was also found to decrease the risk of heart disease amongst those patients who did not respond to normal diabetes treatment.

The study, carried out at the University of Liege in Belgium, showed the positive affects of Acomplia. According to one expert involved in the study, Professor Andre Scheen, "These findings support the use of 20 milligrams per day of rimonabant, in addition to diet and exercise, as a new approach to reduce body weight and improve blood glucose control as well as other cardiovascular risk factors in overweight or obese patients with type 2 diabetes."

The researchers surveyed a study group of over 1,000 overweight and obese diabetic patients. Scheen concluded: "Type 2 diabetes is a difficult disease to treat because we have had no optimal drugs until now. Available drugs can improve blood glucose control but unfortunately they promote weight gain, instead of weight loss."
Leave a Comment
Login via Facebook, Yahoo! and Hotmail
or
Have your full say in the Diabetes Forum
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.